FindTrial
Sign In

Comparison of 0.25% bupivacaine versus 0.25% ropivacaine used for nerve block for post operative pain relief after cesarean section.

A comparative clinical study: 0.25% bupivacaine versus 0.25% ropivacaine for ilioinguinal and iliohypogastric nerve block by loss of resistance technique for Post operative analgesia in LSCS cases

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049903
Enrollment
60
Registered
2023-02-20
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: bilateral ilioinguinal and iliohypogastric nerve block in post caesarean cases.: two drugs will be given to block bilateral ilioinguinal and iliohypogatric nerve post caesarean section

Sponsors

KEMPEGOWDA INSTITUTE OF MEDICAL SCIENCES
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 and 2, scheduled for caesarean section under spinal anesthesia with pfannensteil incision, weight 40-80 kgs

Exclusion criteria

Exclusion criteria: patients with known sensitivity to the drugs, patients with eclampsia and pre eclampsia, incision other than pfannensteil incision, major hepatic, renal, cardiovascular diseases.

Design outcomes

Primary

MeasureTime frame
Duration of analgesia and hemodynamic stability.Timepoint: every 30 minutes for first 2 hours, hourly for next 10 hours, 2 hourly for next 12 hours. Hemodynamic parameters with both the comparison drugs will be assessed as well.—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactDR SWASTIKA AGGARWAL

KEMPEGOWDA INSTITUE OF MEDICAL SCIENCE AND RESEARCH CENTRE

swastika247@gmail.com09986068324

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026